DMKJ
PTHS

David M. Knott Jr’s Pelthos Therapeutics PTHS Stock Holding History

David M. Knott Jr’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$443K Buy
21,073
+1,792
+9% +$42.5K 0.26% 48
2025
Q4 		$598K Buy
19,281
+13,169
+215% +$380K 0.28% 46
2025
Q3 		$171K Buy
+6,112
New +$148K 0.07% 64

Other funds holding PTHS

M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $588M AUM 182.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

David M. Knott Jr's PTHS Position: Q1 2026 in Review

David M. Knott Jr increased its Pelthos Therapeutics (PTHS) stake by 9.3% in Q1 2026, buying an estimated $42.5K and bringing the position to 21,073 shares worth $443K. The position accounts for 0.26% of the portfolio, ranked #48.

David M. Knott Jr first reported a position in PTHS in Q3 2025 and has held it in 3 quarters since. The position peaked at $598K in Q4 2025. 17 funds tracked by Wall St. Rank hold PTHS as of Q1 2026.

  • David M. Knott Jr held 21,073 shares of Pelthos Therapeutics worth $443K as of Q1 2026.
  • David M. Knott Jr bought 1,792 Pelthos Therapeutics shares in Q1 2026, an estimated $42.5K.
  • Pelthos Therapeutics made up 0.26% of David M. Knott Jr's portfolio in Q1 2026, its #48 holding.
  • David M. Knott Jr first reported a position in Pelthos Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • David M. Knott Jr's Pelthos Therapeutics position peaked at $598K in Q4 2025.
  • 17 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q1 2026.

Based on David M. Knott Jr's 13F filing for Q1 2026, filed 14 May 2026.